Gain Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Gain Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 24, 2026, to elect directors and ratify auditor selection.
NASDAQ
DEFA14A: Gain Therapeutics to Hold Annual Stockholders Meeting, Proposes Increase in Authorized Shares
Gain Therapeutics will hold its annual stockholders meeting on June 24, 2025, to vote on director elections, auditor ratification, an increase in authorized shares, and adjournment options.
NASDAQ
Gain Therapeutics is holding its 2025 Annual Meeting of Stockholders to elect directors, ratify the selection of its accounting firm, and approve an increase in authorized common stock.
NASDAQ
Gain Therapeutics announces its 2024 Annual Meeting of Stockholders to be held on June 24, 2024, with key proposals including the election of directors and ratification of the company's independent auditor.
NASDAQ
Gain Therapeutics announces its 2024 Annual Meeting of Stockholders to be held on June 24, 2024, to elect directors and ratify the selection of its independent accounting firm.